slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 222,481-222,510
Pages 10,126
Rows per page 30
Component
222,481-222,510 of 303,780
19
The slide uses a biological pathway diagram to illustrate the mechanism of action of the drug candidate.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
20
The table compares key metrics like EC50, half-life, brain:plasma ratio, selectivity, bioavailability, and molecular weight.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
21
The slide uses a biological pathway diagram to illustrate the mechanism of action (PAM) and the pathology of schizophrenia.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
22
Includes a biological mechanism diagram showing the inhibition of TDP-43 phosphorylation by NMRA-CK1δ.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
23
MVAE stands for Multimodal Variational Autoencoder.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
24
The slide uses a biological pathway diagram to illustrate the mechanism of action of the drug candidate.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
25
Includes a detailed biological pathway diagram illustrating the mechanism of action.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
26
The slide uses a linear process flow (Challenge -> Toolbox -> Value) to explain the company's methodology.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
27
Neumora Therapeutics | IPO Presentation Deck | 32 slidesNeumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
28
Neumora Therapeutics | IPO Presentation Deck | 32 slidesNeumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
29
Neumora Therapeutics | IPO Presentation Deck | 32 slidesNeumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
30
The slide uses a table to demonstrate IP defensibility and a green footer section to categorize the IP strategy.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
31
Clinical trial baseline characteristics table.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
32
The slide uses two line charts to visualize clinical trial data with p-values and delta LSM values.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
01
Features a medical professional in surgical attire.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations 1 hit
02
Orthofix | Investor Presentation Deck | 22 slidesOrthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations 1 hit
06
Orthofix | Investor Presentation Deck | 22 slidesOrthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
11
The slide uses a donut chart to show revenue composition and highlights global reach.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Business ModelLoop · Golden Circle1 hit
12
The central diagram is a complex network graph connecting six strategic pillars to a central hub.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Loop · Golden Circle1 hit
13
The slide uses a grid layout to present distinct business growth levers.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Loop · Golden Circle1 hit
15
Includes disclaimer regarding the date of guidance and growth rate context.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · FinancialsLoop · Golden Circle1 hit
16
The slide uses a three-column layout to categorize the merger benefits.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · FinancialsLoop · Golden Circle1 hit
18
The slide uses a high-contrast visual style with a digital circuit-board texture inside the text.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Financials1 hit
19
Orthofix | Investor Presentation Deck | 22 slidesOrthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Financials1 hit
20
Includes detailed breakdown of adjustments for Q2 2022 and Q2 2023.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Financials1 hit
21
This is a standard financial disclosure slide providing a bridge between GAAP loss and non-GAAP adjusted EBITDA.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Financials1 hit
22
Includes a detailed footnote regarding SeaSpine reclassifications and a paragraph explaining the proforma methodology for the merger.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Financials1 hit
02
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Interest1 hit
03
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Interest1 hit
04
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Interest1 hit